• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Satellos Bioscience Inc. - Common Stock (NQ:MSLE)

9.790 +0.350 (+3.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 165,890
Open 9.340
Bid (Size) 9.430 (1,500)
Ask (Size) 9.850 (600)
Prev. Close 9.440
Today's Range 9.340 - 10.00
52wk Range 5.440 - 13.39
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update ↗
July 10, 2026
Satellos Bioscience (NASDAQ:MSLE) said interim six-month data from its ongoing TRAILHEAD study showed encouraging safety and efficacy signals for SAT-3247, its investigational therapy for Duchenne... 
Via MarketBeat
News headline image
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 24, 2026
From Satellos Bioscience Inc.
Via Business Wire

Performance

YTD
-13.0%
-13.0%
1 Month
+66.5%
+66.5%
3 Month
+50.6%
+50.6%
6 Month
-13.0%
-13.0%
1 Year
-13.0%
-13.0%

More News

Read More
News headline image
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
February 18, 2026
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos to Participate in Upcoming Investor Conferences
February 17, 2026
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
February 10, 2026
From Satellos Bioscience Inc.
Via Business Wire
News headline image
Why MSLE Stock Gave Up All Nasdaq Debut Gains And Fell 8% After Hours ↗
February 10, 2026
Via Stocktwits
News headline image
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
February 09, 2026
From Satellos Bioscience Inc.
Via Business Wire

Frequently Asked Questions

Is Satellos Bioscience Inc. - Common Stock publicly traded?
Yes, Satellos Bioscience Inc. - Common Stock is publicly traded.
What exchange does Satellos Bioscience Inc. - Common Stock trade on?
Satellos Bioscience Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Satellos Bioscience Inc. - Common Stock?
The ticker symbol for Satellos Bioscience Inc. - Common Stock is MSLE on the Nasdaq Stock Market
What is the current price of Satellos Bioscience Inc. - Common Stock?
The current price of Satellos Bioscience Inc. - Common Stock is 9.790
When was Satellos Bioscience Inc. - Common Stock last traded?
The last trade of Satellos Bioscience Inc. - Common Stock was at 07/10/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap